Mutations in IDH genes result in alteration of cellular metabolism, impaired cell adaptation mechanisms, epigenetic dysregulation, and they are associated with a poor prognosis in patients with AML [62,63,64,65]. This evidence concerns the gene IDH2 and acute myeloid leukemia.